Biography
Research Interests
Bernard's research focusses on two themes, 'Medicine Quality' and 'Healthcare Innovation'. More specifically he is interested in behaviours, technology, and regulation concerning the global health issue of substandard and falsified medicine. Regarding healthcare innovation, he is interested in the social processes of innovation, especially barriers to innovation, and responsible innovation. His research has implications for healthcare, governments, the pharmaceutical industry, major projects, and entrepreneurship. He uses both qualitative and quantitative research methods and has published in high impact journals such as BMJ Global Health and Lancet Global Health. He has also contributed to the regulatory affair's professional society, where he has authored several book chapters.
Background
Bernard is an Assistant Professor and interdisciplinary researcher at the School of Pharmacy and Pharmaceutical Sciences at Trinity College Dublin where he is also the Director of the MSc in Pharmaceutical Manufacturing Technology. Prior to this appointment, Bernard was a research fellow at the Saïd Business School, and a member of St Antony's College, at the University of Oxford. Bernard holds a PhD in science and technology in medicine which was jointly supervised by the University of Oxford, Saïd Business School and the Institute of Science and Technology at Keele University. Bernard is a clinical pharmacist by training and has over ten years' experience working with large NHS teaching hospitals.
Funders
Bernards research has been funded by The University of Oxford, the Norwegian Research Council, the Wellcome Trust, and private technology firms.
Other Engagements
Bernard is an associate editor for the Sage journal 'Medicines Access at Point of Care', a tutor at the creative destructive lab at the University of Oxford, and a Visiting Senior Lecturer in the Department of Cancer & Pharmaceutical Sciences, within the Faculty of Life Sciences & Medicine at King's College London. Bernard has also consulted for charities, education providers, professional and regulatory bodies, and the pharmaceutical industry.
Publications and Further Research Outputs
Peer-Reviewed Publications
Niarchou E, Roberts LH, Naughton BD., What is the impact of antidepressant side effects on medication adherence among adult patients diagnosed with depressive disorder: A systematic review., Journal of psychopharmacology (Oxford, England), 38, (2), 2024, p127-136
BD Naughton, MJ Gill, M Field, S Shaw, Impure innovation: Intra-professional stigmatization of radical ideas, 39th EGOS Colloquium, Cagliari 2023, Cagliari, Italy, 2023
Muireann Counihan, Larisa Cervenakova, Dominika Misztela, Maarten Van Baelen and Bernard D. Naughton, Access and use of immunoglobulins in secondary supportive cancer care: A systematic literature review, The Journal of Medicine Access, 2023, p10.1177/27550834231197315
Bernard Naughton, Responsible impact and the reinforcement of responsible innovation in the public sector ecosystem: cases of digital health innovation, Journal of Responsible Innovation , 2023
Bernard David Naughton, Ebru Akgul, Medicine quality in high-income countries: The obstacles to comparative prevalence studies, Medicine Access @ Point of Care, 5, 2021, p239920262110522
Transformation2: leading a megaproject turnaround in, Edward Elgar Publishing, 2021, pp62-83 , [Naughton, Bernard, Maylor, Harvey]
Newton, Paul N, Bond, Katherine C, Adeyeye, Moji, Antignac, Marie, Ashenef, Ayenew, Awab, Ghulam Rahim, Babar, Zaheer-Ud-Din, Bannenberg, Wilbert J, Bond, Katherine C, Bower, Jason, Breman, Joel, Brock, Aleisha, Caillet, Céline, Coyne, Philip, Day, Nicholas, Deats, Michael, Douidy, Kawtar, Doyle, Kim, Dujardin, Catherine, Ejekam, Chioma S, Fernández, Facundo, Freifeld, Clark, Gill, Marie, Guerin, Philippe J, Harigwo, Georgina, Heide, Lutz, Horby, Peter, Kaur, Harparkash, Kayumba, Pierre Claver, Kazuko, Kimura, Kelly, Cassandra, Khuluza, Felix, Kigera, Stephen, Lalani, Mirza, Lamy, Marie, Lieberman, Marya, Lumpkin, Murray, Mackey, Tim, Naughton, Bernard, Newton, Paul N, Nguyen, Philip, Olliaro, Piero, Ozawa, Sachiko, Patel, Anushka, Phanouvong, Souly, Pisani, Elizabeth, Pyzik, Oksana, Rägo, Lembit, Rahman, Mohammad Sofiqur, Ranjit, Eurek, Ravinetto, Raffaella, Richmond, David, Singh-Phulgenda, Sauman, Venema, Jaap, Vogt, Andrea, White, Nicholas, Wirtz, Veronika J, Zaman, Muhammad, COVID-19 and risks to the supply and quality of tests, drugs, and vaccines, The Lancet Global Health, 8, (6), 2020, pe754-e755
McManus D, Naughton BD., A systematic review of substandard, falsified, unlicensed and unregistered medicine sampling studies: a focus on context, prevalence, and quality., BMJ global health, 5, (8), 2020
Naughton BD., Medicine authentication technology: a quantitative study of incorrect quarantine, average response times and offline issues in a hospital setting., BMJ Open, 9, (2), 2019, pe026619
Responsible innovation and commercialisation in the university context: a case study of an academic entrepreneur in digital healthcare in, editor(s)Tatiana Iakovleva, Elin M Oftedal, John Bessant , Responsible Innovation in Digital Health, Cheltenham UK, Edward Elgar Publishing, 2019, ppdoi.org/10.4337/978178 , [Bernard Naughton, Lene Foss]
Newton PN, Bond KC, Oxford Statement signatories., Global access to quality-assured medical products: the Oxford Statement and call to action., The Lancet. Global health, 7, (12), 2019, pe1609-e1611
Pathways for Prosperity Commission, The future of falsified and substandard medicine detection: digital methods to track and authenticate pharmaceutical products, 2018
Merks P, Swieczkowski D, Byliniak M, Drozd M, Krupa K, Jaguszewski M, Brindley DA, Naughton BD., The European Falsified Medicines Directive in Poland: background, implementation and potential recommendations for pharmacists., Eur J Hosp Pharm, 25, (1), 2018, p10-15
Naughton B, Roberts L, Dopson S, Brindley D, Chapman S., Medicine authentication technology as a counterfeit medicine-detection tool: a Delphi method study to establish expert opinion on manual medicine authentication technology in secondary care., BMJ Open, 7, (5), 2017, pe013838
Bernard Naughton (selected chapters), The Oxford Handbook of Clinical Pharmacy, Oxford University Press, 2017
Traceability and Supply Chain in, Fundamentals of US Regulatory Affairs, 2017, [Naughton B, Koshkouei M, Brindley D]
Naughton, Bernard D., The EU Falsified Medicines Directive: Key Implications for Dispensers, Medicine Access @ Point of Care, 1, 2017, pmaapoc.0000024
International Counterfeit Medicine Regulation in, Fundamentals of International Regulatory Affairs, Regulatory Affairs' Professional Society, 2017, [Naughton B, Koshkouei M, Brindley D et al]
Naughton BD, Smith JA, Brindley DA., Establishing good authentication practice (GAP) in secondary care to protect against falsified medicines and improve patient safety., Eur J Hosp Pharm, 23, (2), 2016, p118-120
Naughton B, Roberts L, Dopson S, Chapman S, Brindley D., Effectiveness of medicines authentication technology to detect counterfeit, recalled and expired medicines: a two-stage quantitative secondary care study., BMJ Open, 6, (12), 2016, pe013837
DA, Pettitt, S, Raza, The Limitations of QALY: A Literature Review, Journal of Stem Cell Research & Therapy, 06, (04), 2016
Naughton, BD, Vadher, B, Smith, J, Smith, G, Chapman, SR, Dopson, S, Brindley, DA, EU Falsified Medicines Directive mandatory requirements for secondary care: A concise review, Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector, 12, (3-4), 2015, p95-101
European Union Falsified Medicines Directive: Requirements and Implications for Multi-Stakeholder Healthcare Delivery in, Fundamentals of EU Regulatory Affairs, 2015, [Smith, J., Naughton, B., and Kramm, A]
Stephen R Chapman, Nicholas Thayer, Bernard Naughton, UK/USA Differences in Marketing Claim, Pharmacoepidemiology and Drug Safety, 2010
Non-Peer-Reviewed Publications
L Roberts, BD Naughton, E Niarchiou, Patient Perspectives of medicine use, adherence and doctor-patient communication: A Service Evaluation of the "Open Up About Medicines" Campaign, Midlands Health Psychology Network 18th Annual Conference, 26, Online, 2023
EN L. Roberts, B.D. Naughton, An analysis of the impact of antidepressant side effects on medication adherence among adults with a diagnosed mental disorder, All Ireland Schools of Pharmacy Conference, 2023
Bernard Naughton, Pharmaceutical Serialisation & Traceability; Approaches, Legislation, Challenges & Opportunities , Tackling Illicit Trade in Trinidad and Tobago, Online, July , 2021, British High Commission
Bernard Naughton, In a time of pandemic, we need to stamp out quackery, Oxford, UK, 2020
Bernard Naughton, Counterfeit medicine, illegal substances and Falsified Medicines Directive (FMD), Royal Pharmaceutical Society of Great Britain Science and Research Summit, London, 2019, Royal Pharmaceutical Society of Great Britain
Bernard Naughton, West Midlands Chief Pharmacist Symposium, England, Staffordshire, 2018
Bernard Naughton, 23rd European Association of Hospital Pharmacists Conference, Gothenburg, 2018
Bernard Naughton, 7th Annual Anti-Counterfeiting and Serialisation Conference, London, 2018
Bernard Naughton, 3rd Anti-Counterfeiting Pharma Conference, London, 2017
Bernard Naughton, Fulfilling Patient Needs; A View From The Sharp End, 22nd European Association of Hospital Pharmacists Conference, Cannes, France, March, 2017, European Associate of Hospital Pharmacists
Bernard Naughton, Combating Counterfeit Medicines: Legal Frameworks and Emerging Technologies, The Regulatory Affairs Professional Society, 2016
Bernard Naughton, 5th Annual Anti-Counterfeiting and Serialisation Conference, London, 2016
Research Expertise
Description
My research focusses on two themes, 1. Medicine Quality and 2. Healthcare Innovation. More specifically he is interested in estimating the problem as well as behaviour, technology, and regulation concerning substandard and falsified medicine. Regarding healthcare innovation, I am interested in the social processes of innovation, especially barriers to innovation, and responsible innovation. My research has implications for healthcare, governments, the pharmaceutical industry, major projects, and entrepreneurship. He uses both qualitative and quantitative research methods and has published in high impact journals such as BMJ Global Health and Lancet Global Health. I have also contributed to the regulatory affair's professional society, where I have authored several book chapters.Projects
- Title
- Hybrid stigma in the digital research and innovation context
- Summary
- This study investigated the effect of Stigma on Innovation in the digital health sector
- Funding Agency
- Wellcome Trust
- Title
- The Future of Falsified and Substandard Medicine. Detection: Digital Methods to Track and Authenticate Pharmaceutical Products. A policy case study.
- Summary
- Working with the Blavatnik School of Government at the University of Oxford and as part of the Pathways for Prosperity project I contributed a case study regarding digital technologies to address the issue of substandard and falsified medicines in low income countries.
- Funding Agency
- Bill and Melinda Gates Foundation.
- Date From
- 2017
- Date To
- 2018
Recognition
Representations
Associate Editor: Journal of Medicine Access
Associate Editor for the Journal of Medicine Access
Visiting Senior Lecturer, Department of Cancer & Pharmaceutical Sciences, within the Faculty of Life Sciences & Medicine at King's College London
QP Forum Steering Committee Member
External Examiner for Technological University Dublin
External Examiner South East Technological University
Falsified Medicines Advisory board member for UK Government MHRA (Medicines Healthcare and Regulatory Authority).
Journal reviewer for the Academy of Management
Journal reviewer for Health Services Research
Journal Reviewer for Health Services Research (2022)
Journal reviewer for the Journal of King Saud University
Journal reviewer for the International Journal of Environmental Research and Public Health (Reviewer Board Member)
Reviewer for the MDPI journal Pharmacy
Reviewer for Lancet Oncology
Reviewer for Sustainability
Reviewer for Therapeutic Innovation and Regulatory Science
Editorial Board Member at The Journal of Medicine Access
Regular Journal Reviewer for BMJ Global Health
Principal Consultant. Solfen Healthcare Limited.
Reviewer Board member for The International Journal of Environmental Research and Public Health
Memberships
Royal Pharmaceutical Society of Great Britain
Academy of Management
Regulatory Affairs Professional Society